Skip to Content

Bordetella Bronchiseptica Intranasal Vaccine

This page contains information on Bordetella Bronchiseptica Intranasal Vaccine for veterinary use.
The information provided typically includes the following:
  • Bordetella Bronchiseptica Intranasal Vaccine Indications
  • Warnings and cautions for Bordetella Bronchiseptica Intranasal Vaccine
  • Direction and dosage information for Bordetella Bronchiseptica Intranasal Vaccine

Bordetella Bronchiseptica Intranasal Vaccine

This treatment applies to the following species:
Manufacturer: MVP Labs.

Bordetella bronchiseptica Vaccine (Avirulent Live Culture)

U.S. Vet. Lic. No.: 301

Active Ingredient(s): The vaccine contains cultures of avirulent live Bordetella bronchiseptica.

Bordetella Bronchiseptica Intranasal Vaccine Indications

For use as an aid in the prevention of respiratory disease associated with virulent Bordetella bronchiseptica in swine.

Dosage and Administration

Shake well before and occasionally during use. Administer 1/2 mL into each nostril of piglets within 24 hours of birth.

Precaution(s): Store at 35°-45°F (2°-7°C). Do not freeze.

Caution(s): Use the entire contents when first opened. Burn the container and any unused contents after use.

For veterinary use only.

Warning(s): Do not use within 21 days before slaughter.

Presentation: 30 mL (30 dose) and 100 mL (100 dose) vials.

NAC No.: 11120000

MVP LABORATORIES, INC.
Distributed by PHIBRO ANIMAL HEALTH CORPORATION
GLENPOINTE CENTRE EAST, 300 FRANK W. BURR BOULEVARD, SUITE #21, TEANECK, NJ, 07666
Telephone:   201-329-7300
Customer Service:   888-403-0074
Fax:   201-329-7070
Website:   www.pahc.com
Every effort has been made to ensure the accuracy of the Bordetella Bronchiseptica Intranasal Vaccine information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2017 North American Compendiums. Updated: 2017-07-10

Hide